Inactive Instrument

AMT HOLDING Stock

Equities

NL0000886968

Biotechnology & Medical Research

End-of-day quote Euronext Amsterdam Other stock markets
- ^EUR	-

Press releases AMT HOLDING

AMT HOLDING : Amsterdam Molecular Therapeutics Reports Full Year Results 2011	12-04-27	PU
AMT HOLDING : Amsterdam Molecular Therapeutics rondt uitkering bij voorbaat van uniQure certificaten aan AMT aandeelhouders af	12-04-26	PU
AMT HOLDING : Amsterdam Molecular Therapeutics Receives Further Opinion on Glybera® Marketing Authorisation Application	12-04-23	PU
AMT HOLDING : Progenika Receives CE Mark for First DNA Chip to Detect Mutations in Lipoprotein Lipase (LPL) Gene	10-09-27	PR
AMT HOLDING : Obtains License to Amgen's GDNF Gene to Develop Treatment for Parkinson's Disease with AMT's Proprietary Gene Therapy Platform	08-09-18	GL

More press releases

News in other languages on AMT HOLDING

AMT HOLDING : AMT's Marketing Authorisation Application voor Glybera(R) verloopt op schema	10-08-18
AMT HOLDING : erhält Lizenz für das Amgen-GDNF-Gen zur Entwicklung einer Therapie für Parkinson mit Hilfe der proprietären AMT-Gentherapie-Plattform	08-09-18
AMT HOLDING : gibt positive klinische Zwischenergebnisse für das Hauptprodukt AMT-011 bekannt	08-05-30

Company Profile

Sector

Biotechnology & Medical Research

More about the company

Sector Other Biotechnology & Medical Research

	1st Jan change	Capi.
IQVIA HOLDINGS INC.	+1.77%	42.75B
LONZA GROUP AG	+47.70%	41.61B
MODERNA, INC.	+12.24%	41.34B
CELLTRION, INC.	-8.83%	26.59B
ICON PUBLIC LIMITED COMPANY	+7.44%	25.49B
ALNYLAM PHARMACEUTICALS, INC.	-23.01%	18.12B
MEDPACE HOLDINGS, INC.	+30.56%	12.24B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	-1.82%	11.76B
UNITED THERAPEUTICS CORPORATION	+8.35%	11B

Other Biotechnology & Medical Research

The best tools reserved for subscribers to boost the performance of your investments!

Optimize my profits

fermer